Golden
Inoviv

Inoviv

Inoviv develops proteomics-based biomarker tests to support pharmaceutical companies in running clinical trials.

All edits by  Dawson Sewell 

Edits on 17 Apr 2019
Dawson Sewell
Dawson Sewell edited on 17 Apr 2019 6:45 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 11 Apr 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 11 Apr 2019 7:14 pm
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 30 Mar 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 30 Mar 2019 1:11 am
Edits made to:
Article (+17/-17 characters)

Article

Inoviv’s services include Patient Identification and Stratification, Companion Diagnostics and Treatment Efficacy Monitoring. The company measures more than 50 calibrating molecules per biofluid sample and analyzes 3000 biofluid/tissue samples per day. Their technology uses mass spectrometry-based targeted proteomics to test multiplexed protein, peptide, lipid and metabolite biomarker panels. Mass spectrometryMass spectrometry measures the mass-to-charge ratio of molecules. Inoviv’s uses a triple quadrupole mass spectrometry system. 

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 29 Mar 2019 10:33 pm
Edits made to:
Article (+18/-18 characters)

Article

Inoviv pitched at Entrepreneur FirstEntrepreneur First’s 9th demo day in 2018.

No more activity to show.